Amylin as a Future Obesity Treatment
Obesity is defined as abnormal or excessive fat accumulation that contributes to detrimental health impacts. One-third of the population suffers from obesity, and it is important to consider obesity as a chronic disease requiring chronic treatment. Amylin is co-secreted with insulin from β pancreati...
Main Authors: | Babak Dehestani, Nicholas RS Stratford, Carel W le Roux |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for the Study of Obesity
2021-12-01
|
Series: | Journal of Obesity & Metabolic Syndrome |
Subjects: | |
Online Access: | http://journaleditor.inforang.com/journal/view.html?doi=10.7570/jomes21071 |
Similar Items
-
Clinical Impact of Liraglutide as a Treatment of Obesity
by: Alruwaili H, et al.
Published: (2021-03-01) -
Are Dietary Proteins the Key to Successful Body Weight Management? A Systematic Review and Meta-Analysis of Studies Assessing Body Weight Outcomes after Interventions with Increased Dietary Protein
by: Thea Toft Hansen, et al.
Published: (2021-09-01) -
A paradigm shift for the prevention and treatment of individual and global obesity
by: Slyper AH
Published: (2018-11-01) -
Is reduction in appetite beneficial for body weight management in the context of overweight and obesity? Yes, according to the SATIN (Satiety Innovation) study
by: Thea Toft Hansen, et al.
Published: (2019-01-01) -
Circulating Metabolites Associated with Postprandial Satiety in Overweight/Obese Participants: The SATIN Study
by: Lucía Camacho-Barcia, et al.
Published: (2021-02-01)